The mechanism of action of the insulin-like growth factor-1/insulin-like growth factor-1 receptor signaling pathway in regulating liver fibrosis
- VernacularTitle:胰岛素样生长因子-1/胰岛素样生长因子-1受体信号通路调控肝纤维化的作用机制
- Author:
Yan CUI
1
;
Jingtao LI
2
;
Junzhe JIAO
2
;
Zhanjie CHANG
2
;
Haibo ZHANG
1
Author Information
- Publication Type:Review
- Keywords: Insulin-Like Growth Factor I; Hepatic Fibrosis; DNA Damage; Signal Transduction
- From: Journal of Clinical Hepatology 2026;42(2):445-451
- CountryChina
- Language:Chinese
- Abstract: Liver fibrosis is caused by various factors such as viral infection， alcohol intake， and metabolism-related damage， leading to the replacement of normal tissue by fibrous scars. As a regulatory factor for cell proliferation， insulin-like growth factor 1 （IGF-1） participates in the regulation of cell cycle， the promotion of cell proliferation and differentiation， and the inhibition of cell apoptosis by binding to its receptor insulin-like growth factor-1 receptor （IGF-1R）. Studies have shown that the IGF-1/IGF-1R signaling pathway can regulate the process of liver fibrosis by affecting the senescence and apoptosis of hepatocytes， the activation and proliferation of hepatic stellate cells， and the dysfunction of endothelial cells. In addition， the IGF-1/IGF-1R signaling system can also regulate multiple mechanisms such as DNA damage repair， cell proliferation， lipid metabolism， cell senescence， and oxidative stress， thereby providing new strategies and potential targets for the prevention and treatment of liver fibrosis. This article summarizes the mechanism of action of IGF-1/IGF-1R and its signal transduction system in mediating liver fibrosis by regulating DNA damage repair in different cells， in order to provide a theoretical basis for the treatment of liver fibrosis.
